<VariationArchive VariationID="823" VariationName="NM_000038.6(APC):c.4612_4613del (p.Glu1538fs)" VariationType="Deletion" Accession="VCV000000823" Version="21" RecordType="classified" NumberOfSubmissions="8" NumberOfSubmitters="8" DateLastUpdated="2024-07-29" DateCreated="2013-09-14" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="15862" VariationID="823">
      <GeneList>
        <Gene Symbol="APC" FullName="APC regulator of WNT signaling pathway" GeneID="324" HGNC_ID="HGNC:583" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q22.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="112707498" stop="112846239" display_start="112707498" display_stop="112846239" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="112043201" stop="112181935" display_start="112043201" display_stop="112181935" Strand="+" />
          </Location>
          <OMIM>611731</OMIM>
          <Haploinsufficiency last_evaluated="2021-07-18" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=APC">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-07-18" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=APC">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000038.6(APC):c.4612_4613del (p.Glu1538fs)</Name>
      <CanonicalSPDI>NC_000005.10:112840204:AGA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q22.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="112840205" stop="112840206" display_start="112840205" display_stop="112840206" variantLength="2" positionVCF="112840204" referenceAlleleVCF="CAG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="112175902" stop="112175903" display_start="112175902" display_stop="112175903" variantLength="2" positionVCF="112175901" referenceAlleleVCF="CAG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>E1255fs</ProteinChange>
      <ProteinChange>E1378fs</ProteinChange>
      <ProteinChange>E1412fs</ProteinChange>
      <ProteinChange>E1447fs</ProteinChange>
      <ProteinChange>E1479fs</ProteinChange>
      <ProteinChange>E1497fs</ProteinChange>
      <ProteinChange>E1510fs</ProteinChange>
      <ProteinChange>E1520fs</ProteinChange>
      <ProteinChange>E1538fs</ProteinChange>
      <ProteinChange>E1437fs</ProteinChange>
      <ProteinChange>E1513fs</ProteinChange>
      <ProteinChange>E1548fs</ProteinChange>
      <ProteinChange>E1556fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008481.4" sequenceAccession="NG_008481" sequenceVersion="4" change="g.152685_152686del">
            <Expression>NG_008481.4:g.152685_152686del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.112840206_112840207del" Assembly="GRCh38">
            <Expression>NC_000005.10:g.112840206_112840207del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.112175903_112175904del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.112175903_112175904del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008481.4" sequenceAccession="NG_008481" sequenceVersion="4" change="g.152686_152687del">
            <Expression>NG_008481.4:g.152686_152687del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000038.6" sequenceAccession="NM_000038" sequenceVersion="6" change="c.4612_4613del" MANESelect="true">
            <Expression>NM_000038.6:c.4612_4613del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000029.2" sequenceAccession="NP_000029" sequenceVersion="2" change="p.Glu1538fs">
            <Expression>NP_000029.2:p.Glu1538fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127510.3" sequenceAccession="NM_001127510" sequenceVersion="3" change="c.4612_4613del">
            <Expression>NM_001127510.3:c.4612_4613del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001120982.1" sequenceAccession="NP_001120982" sequenceVersion="1" change="p.Glu1538fs">
            <Expression>NP_001120982.1:p.Glu1538fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127511.3" sequenceAccession="NM_001127511" sequenceVersion="3" change="c.4558_4559del">
            <Expression>NM_001127511.3:c.4558_4559del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001120983.2" sequenceAccession="NP_001120983" sequenceVersion="2" change="p.Glu1520fs">
            <Expression>NP_001120983.2:p.Glu1520fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354895.2" sequenceAccession="NM_001354895" sequenceVersion="2" change="c.4612_4613del">
            <Expression>NM_001354895.2:c.4612_4613del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341824.1" sequenceAccession="NP_001341824" sequenceVersion="1" change="p.Glu1538fs">
            <Expression>NP_001341824.1:p.Glu1538fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354896.2" sequenceAccession="NM_001354896" sequenceVersion="2" change="c.4666_4667del">
            <Expression>NM_001354896.2:c.4666_4667del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341825.1" sequenceAccession="NP_001341825" sequenceVersion="1" change="p.Glu1556fs">
            <Expression>NP_001341825.1:p.Glu1556fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354897.2" sequenceAccession="NM_001354897" sequenceVersion="2" change="c.4642_4643del">
            <Expression>NM_001354897.2:c.4642_4643del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341826.1" sequenceAccession="NP_001341826" sequenceVersion="1" change="p.Glu1548fs">
            <Expression>NP_001341826.1:p.Glu1548fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354898.2" sequenceAccession="NM_001354898" sequenceVersion="2" change="c.4537_4538del">
            <Expression>NM_001354898.2:c.4537_4538del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341827.1" sequenceAccession="NP_001341827" sequenceVersion="1" change="p.Glu1513fs">
            <Expression>NP_001341827.1:p.Glu1513fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354899.2" sequenceAccession="NM_001354899" sequenceVersion="2" change="c.4528_4529del">
            <Expression>NM_001354899.2:c.4528_4529del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341828.1" sequenceAccession="NP_001341828" sequenceVersion="1" change="p.Glu1510fs">
            <Expression>NP_001341828.1:p.Glu1510fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354900.2" sequenceAccession="NM_001354900" sequenceVersion="2" change="c.4489_4490del">
            <Expression>NM_001354900.2:c.4489_4490del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341829.1" sequenceAccession="NP_001341829" sequenceVersion="1" change="p.Glu1497fs">
            <Expression>NP_001341829.1:p.Glu1497fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354901.2" sequenceAccession="NM_001354901" sequenceVersion="2" change="c.4435_4436del">
            <Expression>NM_001354901.2:c.4435_4436del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341830.1" sequenceAccession="NP_001341830" sequenceVersion="1" change="p.Glu1479fs">
            <Expression>NP_001341830.1:p.Glu1479fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354902.2" sequenceAccession="NM_001354902" sequenceVersion="2" change="c.4339_4340del">
            <Expression>NM_001354902.2:c.4339_4340del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341831.1" sequenceAccession="NP_001341831" sequenceVersion="1" change="p.Glu1447fs">
            <Expression>NP_001341831.1:p.Glu1447fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354903.2" sequenceAccession="NM_001354903" sequenceVersion="2" change="c.4309_4310del">
            <Expression>NM_001354903.2:c.4309_4310del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341832.1" sequenceAccession="NP_001341832" sequenceVersion="1" change="p.Glu1437fs">
            <Expression>NP_001341832.1:p.Glu1437fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354904.2" sequenceAccession="NM_001354904" sequenceVersion="2" change="c.4234_4235del">
            <Expression>NM_001354904.2:c.4234_4235del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341833.1" sequenceAccession="NP_001341833" sequenceVersion="1" change="p.Glu1412fs">
            <Expression>NP_001341833.1:p.Glu1412fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354905.2" sequenceAccession="NM_001354905" sequenceVersion="2" change="c.4132_4133del">
            <Expression>NM_001354905.2:c.4132_4133del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341834.1" sequenceAccession="NP_001341834" sequenceVersion="1" change="p.Glu1378fs">
            <Expression>NP_001341834.1:p.Glu1378fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354906.2" sequenceAccession="NM_001354906" sequenceVersion="2" change="c.3763_3764del">
            <Expression>NM_001354906.2:c.3763_3764del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341835.1" sequenceAccession="NP_001341835" sequenceVersion="1" change="p.Glu1255fs">
            <Expression>NP_001341835.1:p.Glu1255fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_130" sequenceAccession="LRG_130">
            <Expression>LRG_130:g.152686_152687del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000038.5" sequenceAccession="NM_000038" sequenceVersion="5" change="c.4612_4613delGA">
            <Expression>NM_000038.5:c.4612_4613delGA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA009642" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="611731.0030" DB="OMIM" />
        <XRef Type="rs" ID="387906236" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000038.6(APC):c.4612_4613del (p.Glu1538fs) AND Gardner syndrome" Accession="RCV000000866" Version="11">
        <ClassifiedConditionList TraitSetID="206">
          <ClassifiedCondition DB="MedGen" ID="C0017097">Gardner syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1997-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000038.6(APC):c.4612_4613del (p.Glu1538fs) AND not provided" Accession="RCV001781152" Version="13">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-07-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000038.6(APC):c.4612_4613del (p.Glu1538fs) AND Hereditary cancer-predisposing syndrome" Accession="RCV002336071" Version="9">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2015-07-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000038.6(APC):c.4612_4613del (p.Glu1538fs) AND Familial adenomatous polyposis 1" Accession="RCV002512626" Version="12">
        <ClassifiedConditionList TraitSetID="6265">
          <ClassifiedCondition DB="MedGen" ID="C2713442">Familial adenomatous polyposis 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-12-13" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000038.6(APC):c.4612_4613del (p.Glu1538fs) AND multiple conditions" Accession="RCV003227591" Version="8">
        <ClassifiedConditionList TraitSetID="81978">
          <ClassifiedCondition DB="MedGen" ID="C0346629">Colorectal cancer</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1851124">Desmoid disease, hereditary</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C2713442">Familial adenomatous polyposis 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4749917">Gastric adenocarcinoma and proximal polyposis of the stomach</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0024623">Gastric cancer</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C2239176">Hepatocellular carcinoma</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-03-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000038.6(APC):c.4612_4613del (p.Glu1538fs) AND Familial multiple polyposis syndrome" Accession="RCV004017217" Version="2">
        <ClassifiedConditionList TraitSetID="8942">
          <ClassifiedCondition DB="MedGen" ID="C0032580">Familial multiple polyposis syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-07-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-13" NumberOfSubmissions="8" NumberOfSubmitters="8" DateCreated="2013-09-14" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">1316610</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15024739</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15311282</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17293347</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20223039</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20513532</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20685668</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21643010</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21779980</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22135120</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22987206</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27081525</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7485167</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8162051</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8381579</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8594558</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9375853</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9824584</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="81978" Type="TraitChoice" ContributesToAggregateClassification="true">
            <Trait ID="18496" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hepatocellular carcinoma</ElementValue>
                <XRef ID="HP:0001402" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0007256" DB="MONDO" />
                <XRef ID="25370001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Primary carcinoma of liver</ElementValue>
                <XRef ID="187769009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hepatoma</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">LIVER CELL CARCINOMA</ElementValue>
                <XRef Type="MIM" ID="114550" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hepatocellular cancer</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HCC</ElementValue>
                <XRef Type="MIM" ID="114550" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">LCC</ElementValue>
                <XRef Type="MIM" ID="114550" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16773" />
                <XRef ID="16773" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/hcc.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Hepatocellular Carcinoma, 2024</CitationText>
              </Citation>
              <XRef ID="88673" DB="Orphanet" />
              <XRef ID="C2239176" DB="MedGen" />
              <XRef ID="MONDO:0007256" DB="MONDO" />
              <XRef Type="MIM" ID="114550" DB="OMIM" />
              <XRef Type="primary" ID="HP:0001402" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002899" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0003007" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0006750" DB="Human Phenotype Ontology" />
            </Trait>
            <Trait ID="15929" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED</ElementValue>
                <XRef Type="Allelic variant" ID="611731.0028" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611731.0034" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611731.0049" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611731.0036" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611731.0038" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611731.0035" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611731.0042" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611731.0043" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611731.0021" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Familial adenomatous polyposis 1</ElementValue>
                <XRef ID="MONDO:0021056" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">POLYPOSIS, ADENOMATOUS INTESTINAL</ElementValue>
                <XRef Type="MIM" ID="175100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">APC-Associated Polyposis Conditions</ElementValue>
                <XRef ID="NBK1345" DB="GeneReviews" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FAP1</ElementValue>
                <XRef Type="MIM" ID="175100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000569916" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552303" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570011" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512645" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000321103" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520869" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520047" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501394" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520394" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508954" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515534" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000172265" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000527984" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520872" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552290" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520077" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522559" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528912" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591173" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552245" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520870" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530028" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000527982" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501393" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512300" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000604264" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500894" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520868" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530118" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530120" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592450" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515899" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521915" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501794" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000593435" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330056" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520069" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558907" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529017" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520865" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530202" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">APC-associated polyposis conditions include (classic or attenuated) familial adenomatous polyposis (FAP) and gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS). FAP is a colorectal cancer (CRC) predisposition syndrome that can manifest in either classic or attenuated form. Classic FAP is characterized by hundreds to thousands of adenomatous colonic polyps, beginning on average at age 16 years (range 7-36 years). For those with the classic form of FAP, 95% of individuals have polyps by age 35 years; CRC is inevitable without colectomy. The mean age of CRC diagnosis in untreated individuals is 39 years (range 34-43 years). The attenuated form is characterized by multiple colonic polyps (average of 30), more proximally located polyps, and a diagnosis of CRC at a later age than in classic FAP. For those with an attenuated form, there is a 70% lifetime risk of CRC and the mean age of diagnosis is 50-55 years. Extracolonic manifestations are variably present and include polyps of the stomach and duodenum, osteomas, dental abnormalities, congenital hypertrophy of the retinal pigment epithelium (CHRPE), benign cutaneous lesions, desmoid tumors, adrenal masses, and other associated cancers. GAPPS is characterized by proximal gastric polyposis, increased risk of gastric adenocarcinoma, and no duodenal or colonic involvement in most individuals reported.</Attribute>
                <XRef ID="NBK1345" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301519</ID>
                <ID Source="BookShelf">NBK1345</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCRS, 2001">
                <ID Source="PubMed">11598466</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2004">
                <ID Source="PubMed">15604628</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21368914</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO/ESMO, 2015">
                <ID Source="PubMed">25452455</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2014">
                <ID Source="PubMed">24310308</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACG, 2015">
                <ID Source="PubMed">25645574</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Colon Cancer, 2024</CitationText>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Colon-Cancer.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Family History ACT Sheet, Colon Cancer (Asymptomatic), 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Familial-Adenomatous-Polyposis-ACT-Sheet.aspx</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, APC Pathogenic Variants (Familial Adenomatous Polyposis [FAP]), 2019</CitationText>
              </Citation>
              <XRef ID="C2713442" DB="MedGen" />
              <XRef ID="MONDO:0021056" DB="MONDO" />
              <XRef Type="MIM" ID="175100" DB="OMIM" />
            </Trait>
            <Trait ID="45251" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Polyposis, gastric, Dos Santos and de Magalhaes 1980</ElementValue>
                <XRef ID="MONDO:0024293" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">POLYPOSIS, GASTRIC</ElementValue>
                <XRef Type="MIM" ID="619182" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Gastric adenocarcinoma and proximal polyposis of the stomach</ElementValue>
                <XRef ID="MONDO:0017790" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GAPPS</ElementValue>
                <XRef Type="MIM" ID="619182" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">POLYPOSIS OF GASTRIC FUNDUS WITHOUT POLYPOSIS COLI</ElementValue>
                <XRef Type="MIM" ID="619182" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">APC-associated polyposis conditions include (classic or attenuated) familial adenomatous polyposis (FAP) and gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS). FAP is a colorectal cancer (CRC) predisposition syndrome that can manifest in either classic or attenuated form. Classic FAP is characterized by hundreds to thousands of adenomatous colonic polyps, beginning on average at age 16 years (range 7-36 years). For those with the classic form of FAP, 95% of individuals have polyps by age 35 years; CRC is inevitable without colectomy. The mean age of CRC diagnosis in untreated individuals is 39 years (range 34-43 years). The attenuated form is characterized by multiple colonic polyps (average of 30), more proximally located polyps, and a diagnosis of CRC at a later age than in classic FAP. For those with an attenuated form, there is a 70% lifetime risk of CRC and the mean age of diagnosis is 50-55 years. Extracolonic manifestations are variably present and include polyps of the stomach and duodenum, osteomas, dental abnormalities, congenital hypertrophy of the retinal pigment epithelium (CHRPE), benign cutaneous lesions, desmoid tumors, adrenal masses, and other associated cancers. GAPPS is characterized by proximal gastric polyposis, increased risk of gastric adenocarcinoma, and no duodenal or colonic involvement in most individuals reported.</Attribute>
                <XRef ID="NBK1345" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17416" />
                <XRef ID="17416" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">FUNDIC GLAND POLYPOSIS</Attribute>
                <XRef Type="MIM" ID="619182" DB="OMIM" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301519</ID>
                <ID Source="BookShelf">NBK1345</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Familial-Adenomatous-Polyposis-ACT-Sheet.aspx</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, APC Pathogenic Variants (Familial Adenomatous Polyposis [FAP]), 2019</CitationText>
              </Citation>
              <XRef ID="314022" DB="Orphanet" />
              <XRef ID="C4749917" DB="MedGen" />
              <XRef ID="MONDO:0017790" DB="MONDO" />
              <XRef Type="MIM" ID="619182" DB="OMIM" />
            </Trait>
            <Trait ID="32349" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Colorectal cancer, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Malignant Colorectal Neoplasm</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Colorectal cancer</ElementValue>
                <XRef ID="UWMG_7884717" DB="CSER _CC_NCGL, University of Washington" />
                <XRef ID="Colorectal+Cancer/1746" DB="Genetic Alliance" />
                <XRef ID="MONDO:0005575" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CRC</ElementValue>
                <XRef ID="GTR000500646" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="114500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Lynch syndrome is characterized by an increased risk for colorectal cancer (CRC) and cancers of the endometrium, ovary, stomach, small bowel, urinary tract, biliary tract, brain (usually glioblastoma), skin (sebaceous adenomas, sebaceous carcinomas, and keratoacanthomas), pancreas, and prostate. Cancer risks and age of onset vary depending on the associated gene. Several other cancer types have been reported to occur in individuals with Lynch syndrome (e.g., breast, sarcomas, adrenocortical carcinoma). However, the data are not sufficient to demonstrate that the risk of developing these cancers is increased in individuals with Lynch syndrome.</Attribute>
                <XRef ID="NBK1211" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301390</ID>
                <ID Source="BookShelf">NBK1211</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Genetics of Colorectal Cancer">
                <ID Source="PubMed">26389505</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="EHTG/ESCP, 2021">
                <ID Source="PubMed">34043773</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2021">
                <URL>https://www.nice.org.uk/guidance/ng151</URL>
                <CitationText>UK NICE Guideline NG151, Colorectal cancer, 2021</CitationText>
              </Citation>
              <XRef ID="C0346629" DB="MedGen" />
              <XRef ID="MONDO:0005575" DB="MONDO" />
              <XRef Type="MIM" ID="114500" DB="OMIM" />
            </Trait>
            <Trait ID="30012" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Stomach cancer</ElementValue>
                <XRef ID="HP:0012126" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Gastric cancer</ElementValue>
                <XRef ID="HP:0012126" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0001056" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Malignant tumor of stomach</ElementValue>
                <XRef ID="363349007" DB="SNOMED CT" />
              </Name>
              <Citation Type="practice guideline" Abbrev="NCCN, 2023">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Gastric Cancer, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/ng83</URL>
                <CitationText>UK NICE Guideline (NG83), Oesophago-gastric cancer: assessment and management in adults, 2023</CitationText>
              </Citation>
              <XRef ID="C0024623" DB="MedGen" />
              <XRef ID="D013274" DB="MeSH" />
              <XRef ID="MONDO:0001056" DB="MONDO" />
              <XRef Type="MIM" ID="613659" DB="OMIM" />
              <XRef Type="primary" ID="HP:0012126" DB="Human Phenotype Ontology" />
            </Trait>
            <Trait ID="1963" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Fibromatosis, familial infiltrative</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Desmoid disease, hereditary</ElementValue>
                <XRef ID="Desmoid+Disease%2C+Hereditary/2216" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FIF</ElementValue>
                <XRef Type="MIM" ID="135290" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">DESMD</ElementValue>
                <XRef Type="MIM" ID="135290" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">APC-associated polyposis conditions include (classic or attenuated) familial adenomatous polyposis (FAP) and gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS). FAP is a colorectal cancer (CRC) predisposition syndrome that can manifest in either classic or attenuated form. Classic FAP is characterized by hundreds to thousands of adenomatous colonic polyps, beginning on average at age 16 years (range 7-36 years). For those with the classic form of FAP, 95% of individuals have polyps by age 35 years; CRC is inevitable without colectomy. The mean age of CRC diagnosis in untreated individuals is 39 years (range 34-43 years). The attenuated form is characterized by multiple colonic polyps (average of 30), more proximally located polyps, and a diagnosis of CRC at a later age than in classic FAP. For those with an attenuated form, there is a 70% lifetime risk of CRC and the mean age of diagnosis is 50-55 years. Extracolonic manifestations are variably present and include polyps of the stomach and duodenum, osteomas, dental abnormalities, congenital hypertrophy of the retinal pigment epithelium (CHRPE), benign cutaneous lesions, desmoid tumors, adrenal masses, and other associated cancers. GAPPS is characterized by proximal gastric polyposis, increased risk of gastric adenocarcinoma, and no duodenal or colonic involvement in most individuals reported.</Attribute>
                <XRef ID="NBK1345" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000553206" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508954" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528912" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529017" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301519</ID>
                <ID Source="BookShelf">NBK1345</ID>
              </Citation>
              <XRef ID="873" DB="Orphanet" />
              <XRef ID="C1851124" DB="MedGen" />
              <XRef Type="MIM" ID="135290" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="206" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="8650" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Gardner's syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polyposis coli and multiple hard and soft tissue tumors</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Intestinal polyposis, osteomas, sebaceous cysts</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Gardner syndrome</ElementValue>
                <XRef ID="Gardner+Syndrome/2989" DB="Genetic Alliance" />
                <XRef ID="MONDO:0019336" DB="MONDO" />
                <XRef ID="60876000" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GS</ElementValue>
                <XRef ID="175100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000527982" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515899" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000527984" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508954" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530120" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528912" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515534" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530202" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6482" />
                <XRef ID="6482" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="ASCRS, 2001">
                <ID Source="PubMed">11598466</ID>
              </Citation>
              <XRef ID="79665" DB="Orphanet" />
              <XRef ID="C0017097" DB="MedGen" />
              <XRef ID="MONDO:0019336" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6265" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15929" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED</ElementValue>
                <XRef Type="Allelic variant" ID="611731.0028" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611731.0034" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611731.0049" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611731.0036" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611731.0038" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611731.0035" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611731.0042" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611731.0043" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611731.0021" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Familial adenomatous polyposis 1</ElementValue>
                <XRef ID="MONDO:0021056" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">POLYPOSIS, ADENOMATOUS INTESTINAL</ElementValue>
                <XRef Type="MIM" ID="175100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">APC-Associated Polyposis Conditions</ElementValue>
                <XRef ID="NBK1345" DB="GeneReviews" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FAP1</ElementValue>
                <XRef Type="MIM" ID="175100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000569916" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552303" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570011" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512645" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000321103" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520869" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520047" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501394" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520394" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508954" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515534" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000172265" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000527984" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520872" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552290" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520077" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522559" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528912" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591173" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552245" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520870" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530028" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000527982" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501393" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512300" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000604264" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500894" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520868" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530118" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530120" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592450" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515899" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521915" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501794" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000593435" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330056" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520069" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558907" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529017" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520865" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530202" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">APC-associated polyposis conditions include (classic or attenuated) familial adenomatous polyposis (FAP) and gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS). FAP is a colorectal cancer (CRC) predisposition syndrome that can manifest in either classic or attenuated form. Classic FAP is characterized by hundreds to thousands of adenomatous colonic polyps, beginning on average at age 16 years (range 7-36 years). For those with the classic form of FAP, 95% of individuals have polyps by age 35 years; CRC is inevitable without colectomy. The mean age of CRC diagnosis in untreated individuals is 39 years (range 34-43 years). The attenuated form is characterized by multiple colonic polyps (average of 30), more proximally located polyps, and a diagnosis of CRC at a later age than in classic FAP. For those with an attenuated form, there is a 70% lifetime risk of CRC and the mean age of diagnosis is 50-55 years. Extracolonic manifestations are variably present and include polyps of the stomach and duodenum, osteomas, dental abnormalities, congenital hypertrophy of the retinal pigment epithelium (CHRPE), benign cutaneous lesions, desmoid tumors, adrenal masses, and other associated cancers. GAPPS is characterized by proximal gastric polyposis, increased risk of gastric adenocarcinoma, and no duodenal or colonic involvement in most individuals reported.</Attribute>
                <XRef ID="NBK1345" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301519</ID>
                <ID Source="BookShelf">NBK1345</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCRS, 2001">
                <ID Source="PubMed">11598466</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2004">
                <ID Source="PubMed">15604628</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21368914</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO/ESMO, 2015">
                <ID Source="PubMed">25452455</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2014">
                <ID Source="PubMed">24310308</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACG, 2015">
                <ID Source="PubMed">25645574</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Colon Cancer, 2024</CitationText>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Colon-Cancer.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Family History ACT Sheet, Colon Cancer (Asymptomatic), 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Familial-Adenomatous-Polyposis-ACT-Sheet.aspx</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, APC Pathogenic Variants (Familial Adenomatous Polyposis [FAP]), 2019</CitationText>
              </Citation>
              <XRef ID="C2713442" DB="MedGen" />
              <XRef ID="MONDO:0021056" DB="MONDO" />
              <XRef Type="MIM" ID="175100" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8942" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6588" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Classic familial adenomatous polyposis</ElementValue>
                <XRef ID="MONDO:0021055" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial polyposis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial adenomatous polyposis of the colon</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial polyposis of the colon</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial intestinal polyposis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial multiple polyposis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary polyposis coli</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Familial multiple polyposis syndrome</ElementValue>
                <XRef ID="72900001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial adenomatous polyposis</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FAP</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FPC</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000500599" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528529" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552184" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529017" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528534" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552183" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6408" />
                <XRef ID="6408" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="Decipher">
                <URL>https://decipher.sanger.ac.uk/syndrome/49</URL>
              </Citation>
              <Citation Type="general" Abbrev="Mallorca group, 2008">
                <ID Source="PubMed">18194984</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Colon Cancer, 2024</CitationText>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Genetics of Colorectal Cancer">
                <ID Source="PubMed">26389505</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Colon-Cancer.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Family History ACT Sheet, Colon Cancer (Asymptomatic), 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Familial-Adenomatous-Polyposis-ACT-Sheet.aspx</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, APC Pathogenic Variants (Familial Adenomatous Polyposis [FAP]), 2019</CitationText>
              </Citation>
              <XRef ID="733" DB="Orphanet" />
              <XRef ID="C0032580" DB="MedGen" />
              <XRef ID="MONDO:0021055" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS175100" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="21016" SubmissionDate="2013-09-12" DateLastUpdated="2013-09-14" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="611731.0030_GARDNER SYNDROME" title="APC, 2-BP DEL, 1538AG_GARDNER SYNDROME" />
        <ClinVarAccession Accession="SCV000021016" DateUpdated="2013-09-14" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1997-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 previously reported patients with severe Gardner phenotype (see 175100) (Davies et al., 1995), Armstrong et al. (1997) identified a 2-bp deletion (1538delAG) in the APC gene, resulting in a frameshift and premature termination. The patients were of different ethnic backgrounds and had different haplotypes, suggesting that the same mutation had arisen in 2 separate populations.</Attribute>
              <Citation>
                <ID Source="PubMed">7485167</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">9375853</ID>
              </Citation>
              <XRef DB="OMIM" ID="175100" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APC" />
          </GeneList>
          <Name>APC, 2-BP DEL, 1538AG</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 1538AG</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="611731.0030" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GARDNER SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4049575" SubmissionDate="2022-01-25" DateLastUpdated="2022-01-29" DateCreated="2022-01-29">
        <ClinVarSubmissionID localKey="NM_000038.5(APC):c.4612_4613del|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002067521" DateUpdated="2022-01-29" DateCreated="2022-01-29" Type="SCV" Version="1" SubmitterName="Genetic Services Laboratory, University of Chicago" OrgID="1238" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-07-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000038.5:c.4612_4613del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10987855</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7336266" SubmissionDate="2023-05-02" DateLastUpdated="2023-05-20" DateCreated="2023-05-20">
        <ClinVarSubmissionID localKey="1458|OMIM:114500;175100;135290;175100;114550;613659;619182;175100;175100" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV003924235" DateUpdated="2023-05-20" DateCreated="2023-05-20" Type="SCV" Version="1" SubmitterName="Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago" OrgID="506344" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-03-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>APC NM_000038.5 exon 15 p.Glu1538Ilefsx5 (c.4612_4613del): This variant has been reported in the literature in at least 8 individuals with Familial Adenomatous Polyposis (FAP) (Gayther 1994 PMID:8162051, Friedl 2005 PMID:20223039, Jang 2010 PMID:20513532, Lagarde 2010 PMID:20685668, Jarry 2011 PMID:21779980, Rohlin 2011 PMID:21643010, Schwarzova 2013 PMID:22987206). This variant is not present in large control databases. This variant is present in ClinVar (Variation ID:823). Evolutionary conservation and computational predictive tools for this variant are limited or unavailable. This variant is a deletion of two nucleotides and creates a premature stop codon 5 amino acids downstream from this location which results in an absent or abnormal protein. Loss of function variants are a known mechanism of disease for this gene (Zhang 2017 PMID:28423402). Of note, this variant occurs within the last exon of this gene; due to its position, it is possible that this protein may escape nonsense mediated decay. However this variant is predicted to affect approximately 45% of the protein and other variants downstream have been reported as Pathogenic. Furthermore, evidence in the literature suggests that variants cluster in this region (Gayther 1994 PMID:8162051). In summary, this variant is classified as pathogenic based on the data above.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh38" Chr="5" alternateAllele="C" referenceAllele="CAG" start="112840204" stop="112840206" variantLength="3" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="114500" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="175100" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="135290" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="175100" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="114550" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613659" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="619182" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="175100" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="175100" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13232579</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7567980" SubmissionDate="2023-10-23" DateLastUpdated="2023-10-28" DateCreated="2023-10-21">
        <ClinVarSubmissionID localKey="3317|OMIM:175100" />
        <ClinVarAccession Accession="SCV004044003" DateUpdated="2023-10-28" DateCreated="2023-10-21" Type="SCV" Version="2" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/8ufcwsf2/myriad_genetics_classification_criteria_2023.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="5" alternateAllele="A" referenceAllele="AGA" start="112175902" stop="112175904" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">3317</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="175100" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13911051</SubmissionName>
          <SubmissionName>SUB13922314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1477843" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2018-05-28">
        <ClinVarSubmissionID localKey="2488059|MedGen:C2713442" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000768087" DateUpdated="2024-02-14" DateCreated="2018-05-28" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8162051</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8594558</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20223039</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20513532</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20685668</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21643010</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21779980</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22987206</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15311282</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17293347</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9824584</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">1316610</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27081525</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8381579</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22135120</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Glu1538Ilefs*5) in the APC gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 1306 amino acid(s) of the APC protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with familial adenomatous polyposis (PMID: 8162051, 8594558, 20223039, 20513532, 20685668, 21643010, 21779980, 22987206). ClinVar contains an entry for this variant (Variation ID: 823). This variant is expected to disrupt the EB1 and HDLG binding sites, which mediate interactions with the cytoskeleton (PMID: 15311282, 17293347). While functional studies have not been performed to directly test the effect on APC protein function, this suggests that disruption of the C-terminal portion of the protein is functionally important. A different truncation (p.Tyr2645Lysfs*14) that lies downstream of this variant has been determined to be pathogenic (PMID: 9824584, 1316610, 27081525, 8381579, 22135120, Invitae). This suggests that deletion of this region of the APC protein is causative of disease. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.112175902_112175903del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2713442" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9056116" SubmissionDate="2024-04-19" DateLastUpdated="2024-04-20" DateCreated="2024-04-20">
        <ClinVarSubmissionID localKey="101485404|Orphanet:ORPHA733" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004848434" DateUpdated="2024-04-20" DateCreated="2024-04-20" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-07-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20685668</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22987206</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9375853</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15311282</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20223039</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8162051</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20513532</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21779980</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21643010</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17293347</ID>
          </Citation>
          <Comment>The p.Glu1538IlefsX5 variant in APC has been previously reported in at least 6 individuals with APC-associated polyposis conditions: 3 with familial adenomatous polyposis (FAP), 3 individuals with Gardner syndrome, and 4 individuals with suspected FAP (Gayther 1994 PMID: 8162051, Armstrong 1997 PMID: 9375853, Friedl 2005 PMID: 20223039, Jang 2010 PMID: 20513532, Lagarde 2010 PMID: 20685668, Jarry 2011 PMID: 21779980, Rohlin 2011 PMID: 21643010, Schwarzová 2013 PMID: 22987206). This variant was also reported by other clinical laboratories in ClinVar (Variation ID: 823) and was absent from large population studies. This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 1538 and leads to a premature termination codon 5 amino acids downstream. This termination codon occurs within the last exon and is, therefore, likely to escape nonsense mediated decay (NMD) and result in a truncated protein that is missing ~46% of the coding region, with 1302 amino acids removed. Truncating variants in the last exon of APC, including multiple variants downstream of this variant, have been reported in individuals with FAP. Furthermore, this truncation is predicted to remove the EB1 and APC-basic domains of the APC protein, and in vitro studies have shown that these domains are important regions for APC-mediated microtubule stability and F-actin interactions (Moseley 2007 PMID 17293347, Wen 2004 PMID 15311282). In summary, this variant meets criteria to be classified as pathogenic for APC-associated polyposis conditions, including autosomal dominant FAP and Gardner syndrome. ACMG/AMP Criteria applied: PVS1, PM2, PS4_Strong.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000038.6:exon 15</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.10:g.112840206_112840207delGA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA733" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14389831</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5121294" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a899499|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002639069" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-07-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15024739</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20223039</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20513532</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8162051</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9375853</ID>
          </Citation>
          <Comment>The c.4612_4613delGA pathogenic mutation, located in coding exon 15 of the APC gene, results from a deletion of two nucleotides between nucleotide positions 4612 and 4613, causing a translational frameshift with a predicted alternate stop codon. This mutation has been detected in multiple individuals with clinical diagnoses of AFAP or FAP (Friedl W, et al. Hered Cancer Clin Pract 2005;3(3):95-114, Vandrovcov&amp;aacute; J, et a. Hum. Mutat. 2004;23(4):397, Jang YH, et al. Cancer Genet. Cytogenet. 2010;200(1):34-9, Gayther SA, et al. Hum. Mol. Genet. 1994;3(1):53-6, Armstrong JG, et al. Hum. Mutat. 1997;10(5):376-80). In addition to the clinical data presented in the literature, since frameshifts are typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000038.5:c.4612_4613delGA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7855390" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000038.6:c.4612_4613del|OMIM:175100" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004200474" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000038.6:c.4612_4613del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="175100" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7567980" TraitType="Disease" MappingType="XRef" MappingValue="175100" MappingRef="OMIM">
        <MedGen CUI="C2713442" Name="Familial adenomatous polyposis 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7855390" TraitType="Disease" MappingType="XRef" MappingValue="175100" MappingRef="OMIM">
        <MedGen CUI="C2713442" Name="Familial adenomatous polyposis 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7336266" TraitType="Disease" MappingType="XRef" MappingValue="619182" MappingRef="OMIM">
        <MedGen CUI="C4749917" Name="Gastric adenocarcinoma and proximal polyposis of the stomach" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="21016" TraitType="Disease" MappingType="Name" MappingValue="GARDNER SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0017097" Name="Gardner syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7336266" TraitType="Disease" MappingType="XRef" MappingValue="175100" MappingRef="OMIM">
        <MedGen CUI="C2713442" Name="Familial adenomatous polyposis 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4049575" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7336266" TraitType="Disease" MappingType="XRef" MappingValue="175100" MappingRef="OMIM">
        <MedGen CUI="C2713442" Name="Familial adenomatous polyposis 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7336266" TraitType="Disease" MappingType="XRef" MappingValue="175100" MappingRef="OMIM">
        <MedGen CUI="C2713442" Name="Familial adenomatous polyposis 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5121294" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7336266" TraitType="Disease" MappingType="XRef" MappingValue="114550" MappingRef="OMIM">
        <MedGen CUI="C2239176" Name="Hepatocellular carcinoma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9056116" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA733" MappingRef="Orphanet">
        <MedGen CUI="C0032580" Name="Familial multiple polyposis syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7336266" TraitType="Disease" MappingType="XRef" MappingValue="175100" MappingRef="OMIM">
        <MedGen CUI="C2713442" Name="Familial adenomatous polyposis 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7336266" TraitType="Disease" MappingType="XRef" MappingValue="613659" MappingRef="OMIM">
        <MedGen CUI="C0024623" Name="Gastric cancer" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1477843" TraitType="Disease" MappingType="XRef" MappingValue="C2713442" MappingRef="MedGen">
        <MedGen CUI="C2713442" Name="Familial adenomatous polyposis 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7336266" TraitType="Disease" MappingType="XRef" MappingValue="135290" MappingRef="OMIM">
        <MedGen CUI="C1851124" Name="Desmoid disease, hereditary" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7336266" TraitType="Disease" MappingType="XRef" MappingValue="114500" MappingRef="OMIM">
        <MedGen CUI="C0346629" Name="Colorectal cancer" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2023-03-03">SCV002017629</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

